Eradicating H. Pylori Reduces Gastric Cancer Risk
- PMID: 29691237
- DOI: 10.1158/2159-8290.CD-NB2018-058
Eradicating H. Pylori Reduces Gastric Cancer Risk
Abstract
Eliminating the bacterial infection Helicobacter pylori in patients with early gastric cancer may reduce the risk of metachronous disease. In a recent study, eradicating the infection reduced patients' risk of developing a subsequent gastric cancer by almost 50% and, in nearly half of patients, decreased the severity of atrophic gastritis.
©2018 American Association for Cancer Research.
Comment on
-
Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer.N Engl J Med. 2018 Mar 22;378(12):1085-1095. doi: 10.1056/NEJMoa1708423. N Engl J Med. 2018. PMID: 29562147 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical